Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05096741 · ClinicalTrials.gov registry record
OCS Liver PROTECT Continuation Post-Approval Study
A clinical trial, sponsored by TransMedics.
- Completed
- Registry status
- 300
- Enrollment target
NCT05096741: Completed study, sponsored by TransMedics.
NCT05096741 is a clinical trial that has completed, run by TransMedics. The registered enrollment target is 300 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05096741 has completed, sponsored by TransMedics.
- COMPLETED
- Registry status
- 300 participants
- Enrollment target
Study Summary
Post-approval observational study of subjects that were enrolled and transplanted in the OCS Liver PROTECT Trial.
Primary Outcome
Liver Graft Survival through 2 years (24 months) after transplantation.
Interventions
- DEVICE OCS Liver
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2016-01-24 |
| Est. Completion | 2021-11-05 |
What the finished NCT05096741 record still lists
NCT05096741 is an observational study that tracks outcomes without assigning an intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which OCS Liver is the first listed.
NCT05096741 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05096741 about?
NCT05096741 is a clinical study titled "OCS Liver PROTECT Continuation Post-Approval Study". Post-approval observational study of subjects that were enrolled and transplanted in the OCS Liver PROTECT Trial.
What is the current status of trial NCT05096741?
This trial is currently completed. The enrollment target is 300 participants. The study started on 2016-01-24. Estimated completion is 2021-11-05.
What interventions are being tested in trial NCT05096741?
The interventions under investigation include: OCS Liver (DEVICE).
Who is sponsoring clinical trial NCT05096741?
This trial is sponsored by TransMedics, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI